Abstract
Secondary pulmonary hypertension (sPH) may develop as a result of few systemic diseases as endocrine diseases, HIV infection, collagen diseases, liver and hematological disorders. In this review we discuss the role of systemic diseases in inducing PH starting from a pathological classification.
Keywords: endothelial nitric oxide synthase, calcitonin, copd, endothelin-1, vasoconstrictor, growth hormone, hiv, myeloid metaplasia
Current Drug Targets - Inflammation & Allergy
Title: Pulmonary Hypertension and Systemic Diseases
Volume: 3 Issue: 4
Author(s): Rossella Paolini, Michela Armigliato and Sergio Zamboni
Affiliation:
Keywords: endothelial nitric oxide synthase, calcitonin, copd, endothelin-1, vasoconstrictor, growth hormone, hiv, myeloid metaplasia
Abstract: Secondary pulmonary hypertension (sPH) may develop as a result of few systemic diseases as endocrine diseases, HIV infection, collagen diseases, liver and hematological disorders. In this review we discuss the role of systemic diseases in inducing PH starting from a pathological classification.
Export Options
About this article
Cite this article as:
Paolini Rossella, Armigliato Michela and Zamboni Sergio, Pulmonary Hypertension and Systemic Diseases, Current Drug Targets - Inflammation & Allergy 2004; 3 (4) . https://dx.doi.org/10.2174/1568010042634613
DOI https://dx.doi.org/10.2174/1568010042634613 |
Print ISSN 1568-010X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-010X |
Related Articles
-
Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases
Cardiovascular & Hematological Disorders-Drug Targets Specific and Sensitive RP-HPLC Method Development and Validation for the Determination of Aripiprazole: Application in Preformulation Screening of Nanoemulsion
Current Nanomedicine Overexpression of a Modified Amaranth Protein in Escherichia coli with Minimal Media and Lactose as Inducer
Recent Patents on Biotechnology Vasopressin in Health and Disease with a Focus on Affective Disorders
Central Nervous System Agents in Medicinal Chemistry Development of New Drugs that Act Through Membrane Receptors and Involve an Action of Inverse Agonism
Recent Patents on CNS Drug Discovery (Discontinued) Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Supplementation, Optimal Status, and Analytical Determination of Vitamin D: Where are we Standing in 2012?
Anti-Cancer Agents in Medicinal Chemistry Serum Uric Acid Level as a Predictive Biomarker of Gestational Hypertension Severity; A Prospective Observational Case-Control Study
Reviews on Recent Clinical Trials Catastrophic Antiphospholipid Syndrome: Lessons from the “CAPS Registry”
Current Rheumatology Reviews Glaucoma and Aging
Current Aging Science Role of Radiopharmaceuticals in Development of Inhaled Drugs
Current Pharmaceutical Design Antithrombotic Treatment after Atrial Fibrillation Ablation
Current Pharmaceutical Design Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation
CNS & Neurological Disorders - Drug Targets Complex Atheromatosis of the Aortic Arch in Cerebral Infarction
Current Cardiology Reviews Pregnancy and Sleep Apnea
Current Respiratory Medicine Reviews A Comparative Literature Review Exploring Hypertension Drugs that Lower Target Organ Damage Above and Beyond Reducing Blood Pressure Based on Research Studies Between 1992 and 2006
Current Hypertension Reviews Mild Systemic Inflammation has a Neuroprotective Effect After Stroke in Rats
Current Neurovascular Research Cerebral Hypoperfusion During Carotid Artery Stenosis can Lead to Cognitive Deficits that may be Independent of White Matter Lesion Load
Current Neurovascular Research Diabetic Retinopathy and Atherosclerosis: is there a Link?
Current Diabetes Reviews Peptidergic Regulation of Pheochromocytoma
Current Pharmacogenomics